Xultophy 100/3.6

Novo Nordisk🇺🇸 United States

FDA Page

Effective Date: Jul 10, 2023
Approval ID: 21335fe4-d395-4501-ac2a-2f20d7520da9
Products: 1 registered
Version: 10

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use XULTOPHY 100/3.6 safely and effectively. See full prescribing information for . Initial U.S. Approval: 2016

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.